Polytherapy in Bipolar Disorder
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Bipolar disorder is a life-long condition that is associated with frequent recurrence/relapse of symptoms. Although putative mood stabilisers, such as lithium, are considered to improve the natural course of bipolar disorder, complete long-term remission is rarely achieved. In order to effectively control mood symptoms and to reduce relapse, clinicians often use polypharmacy to treat patients with bipolar disorder. In this article, we examine the recent literature on treatment strategies in bipolar disorder to determine if combination treatments provide additional benefit over monotherapy for the management of various phases of bipolar disorder. The evidence suggests that for acute mania a combination of lithium or valproate and an atypical antipsychotic is the most effective approach, with approximately 20% more patients responding to the combination than to monotherapy with any antimanic agent. Few studies have examined the use of combination therapy in comparison to monotherapy for bipolar depression. The limited evidence suggests that lithium plus an antidepressant appears to be more effective than lithium alone in those with lower serum lithium concentrations. Similarly, the combination of olanzapine plus fluoxetine is more effective than olanzapine alone. There is consensus that antidepressant monotherapy is not appropriate because of concerns of a manic switch, but monotherapy with lithium or lamotrigine may be adequate for mild to moderate bipolar depression. For main…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“clinical trials suggest that on average about 20% more patients will respond to combination therapy.142, 145, 146”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges
Kane, J. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.1 · Cited by 987
Hirschfeld, R. M. A., Lewis, L., & Vornik, L. A. (2003) · PubMed · Cited by 943
Hirschfeld, R. M. A., Lewis, L., & Vornik, L. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0209 · Cited by 922
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Leucht, S., Pitschel-Walz, G., Abraham, D., & Kissling, W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00105-4 · Cited by 796
Colom, F., Vieta, E., Martínez-Arán, A., Reinares, M., Goikolea, J. M., Benabarre, A., Torrent, C., Comes, M., Corbella, B., Parramon, G., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.402 · Cited by 791
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678
Research works printed but not linked: 13
- McElroy, 1996, J Clin Psychiatry, 57, 142
- Chou, 1991, J Clin Psychopharmacol, 11, 3
- Segal, 1998, Clin Neuropharmacol, 21, 176
- Granneman, 1996, J Clin Psychiatry, 57, 204
- Small, 1995, Psychopharmacol Bull, 31, 265
- Schaff, 1993, J Clin Psychiatry, 54, 380
- Chaudhry, 1983, J Clin Psychiatry, 44, 30
- Onady, 1989, J Clin Psychopharmacol, 9, 387
- Burgess, 2001, Cochrane Database Syst Rev, &NA;, CD003013
- Sachs, 1994, J Clin Psychiatry, 55, 391
- Post, 2001, Bipolar Disord, 3, 259, 10.1034/j.1399-5618.2001.30505.x · doi:10.1034/j.1399-5618.2001.30505.x
- Small, 1990, Psychopharmacol Bull, 26, 25
- Macritchie, 2001, Cochrane Database Syst Rev, &NA;, CD003196
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“In general, combination therapy is preferred to mood stabilizer monotherapy because clinical trials suggest that on average about 20% more patients will respond to combination therapy (143, 146, 147).”
BackgroundSelf-citationGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., WFSBP Task Force on Treatment Guide, Grunze, H., Vieta, E., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902823202 · Cited by 346
“Clinical routine appears to be based on polypharmacy in bipolar patients (Lin et al. 2006; Ghaemi et al. 2006; Wolfsperger et al. 2007; Peh and Tay 2008).”
BackgroundReview of Lithium Effects on Brain and Blood
Young, W. (2009) · Cell Transplantation · doi:10.3727/096368909x471251 · Cited by 287
Patterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders
Baldessarini, R. J., Leahy, L., Arcona, S., Gause, D., Zhang, W., & Hennen, J. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.1.85 · Cited by 280
Setting the stage: from prodrome to treatment resistance in bipolar disorder
Berk, M., Conus, P., Lucas, N., Hallam, K., Malhi, G. S., Dodd, S., Yatham, L. N., Yung, A., & McGorry, P. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00484.x · Cited by 238
Self-citation
Metadata
- Authors
- Lin, D., Mok, H., & Yatham, L. N.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Yatham, Lakshmi N
- Venue
- CNS Drugs
- Published
- 2006
- Volume
- 20
- Issue
- 1
- Pages
- 29-42
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W1981711813
- Cited by
- 91
- References
- 101
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 8 · 2013: 6 · 2012: 2
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- bipolar disorder, polypharmacy, combination therapy, monotherapy, lithium, valproic acid, atypical antipsychotics, olanzapine, fluoxetine, lamotrigine, bipolar depression, manic switch, depressive relapse prevention, acute mania
- MeSH terms
- Antidepressive Agents, Bipolar Disorder, Drug Therapy, Combination, Humans, Antipsychotic Agents, Practice Guidelines as Topic, Antimanic Agents, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polytherapy in Bipolar Disorder. https://app.cochat.ai/papers/10.2165/00023210-200620010-00003
- The paper
- Lin, D., Mok, H., & Yatham, L. N. (2006). Polytherapy in Bipolar Disorder. CNS Drugs. https://doi.org/10.2165/00023210-200620010-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.